Eventide Asset Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-276,200
| Closed | -$1.87M | – | 155 |
|
|
2022
Q4 | $1.87M | Hold |
276,200
| – | – | 0.04% | 134 |
|
|
2022
Q3 | $4.01M | Buy |
+276,200
| New | +$4.01M | 0.08% | 127 |
|
|
2022
Q1 | – | Sell |
-138,821
| Closed | -$1.84M | – | 141 |
|
|
2021
Q4 | $1.84M | Sell |
138,821
-526,860
| -79% | -$6.97M | 0.02% | 142 |
|
|
2021
Q3 | $11.6M | Hold |
665,681
| – | – | 0.15% | 119 |
|
|
2021
Q2 | $16M | Sell |
665,681
-707,319
| -52% | -$16.9M | 0.21% | 104 |
|
|
2021
Q1 | $35.3M | Sell |
1,373,000
-307,000
| -18% | -$7.89M | 0.52% | 70 |
|
|
2020
Q4 | $31.9M | Hold |
1,680,000
| – | – | 0.49% | 67 |
|
|
2020
Q3 | $21.2M | Hold |
1,680,000
| – | – | 0.41% | 69 |
|
|
2020
Q2 | $20.3M | Hold |
1,680,000
| – | – | 0.44% | 68 |
|
|
2020
Q1 | $12.9M | Hold |
1,680,000
| – | – | 0.42% | 69 |
|
|
2019
Q4 | $29.9M | Hold |
1,680,000
| – | – | 0.84% | 45 |
|
|
2019
Q3 | $19.5M | Buy |
1,680,000
+180,000
| +12% | +$2.09M | 0.64% | 57 |
|
|
2019
Q2 | $33.2M | Buy |
1,500,000
+600,000
| +67% | +$13.3M | 1.01% | 31 |
|
|
2019
Q1 | $25.8M | Hold |
900,000
| – | – | 0.89% | 38 |
|
|
2018
Q4 | $17.8M | Hold |
900,000
| – | – | 0.79% | 46 |
|
|
2018
Q3 | $19.9M | Hold |
900,000
| – | – | 0.73% | 48 |
|
|
2018
Q2 | $7.31M | Hold |
900,000
| – | – | 0.3% | 85 |
|
|
2018
Q1 | $8.53M | Buy |
900,000
+191,000
| +27% | +$1.81M | 0.4% | 69 |
|
|
2017
Q4 | $6.91M | Buy |
709,000
+313,000
| +79% | +$3.05M | 0.36% | 73 |
|
|
2017
Q3 | $2.64M | Buy |
396,000
+206,100
| +109% | +$1.37M | 0.15% | 95 |
|
|
2017
Q2 | $1.37M | Buy |
189,900
+91,800
| +94% | +$661K | 0.09% | 105 |
|
|
2017
Q1 | $766K | Buy |
+98,100
| New | +$766K | 0.05% | 110 |
|